SEVERE EOSINOPHILIC ASTHMA
Clinical trials for SEVERE EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new SEVERE EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for SEVERE EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New asthma drug shows promise in real-world greek study
Disease control CompletedThis study followed 152 adults in Greece with severe eosinophilic asthma who were starting benralizumab, a medication that helps control severe asthma. Researchers measured not only standard asthma control but also quality of life, sleep, mood, and physical activity using wearabl…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Real-World study checks if benralizumab tames severe asthma in taiwan
Disease control CompletedThis study looked at 43 adults in Taiwan with severe eosinophilic asthma who were already prescribed benralizumab. Researchers tracked changes in asthma control using a standard questionnaire over time. The goal was to see how well the drug works in everyday medical practice, not…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Asthma drug benralizumab put to the test in everyday life
Disease control CompletedThis study looked at how well benralizumab (Fasenra) works for people with severe eosinophilic asthma in real-world clinics across the Gulf, Latin America, and India. Researchers tracked 291 patients to see if their asthma control improved over time using a standard questionnaire…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Real-World FASENRA study completed in korea: safety under the microscope
Disease control CompletedThis completed study looked at the safety and effectiveness of FASENRA (benralizumab) in 51 Korean adults with severe eosinophilic asthma or eosinophilic granulomatosis with polyangiitis (EGPA). Researchers tracked side effects and how well the drug controlled symptoms during rou…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Real-world study confirms mepolizumab cuts asthma attacks and steroid use
Disease control CompletedThis study followed 106 adults with severe eosinophilic asthma in Poland who received mepolizumab injections every 4 weeks for at least a year. Researchers tracked asthma attacks and the need for oral steroids before and during treatment. The goal was to see if the drug helps con…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: Medical University of Lodz • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
CT scan could predict asthma drug success, saving months of trial and error
Knowledge-focused CompletedThis study tested whether a CT scan of the lungs could predict which patients with severe eosinophilic asthma would respond well to the drug benralizumab. 59 adults received benralizumab for 48 weeks and had CT scans at the start, middle, and end of treatment. The goal was to see…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Asthma Drug's hidden effects revealed in small study
Knowledge-focused CompletedThis study looked at how mepolizumab, a biologic drug, changes inflammation in people with severe eosinophilic asthma. Researchers measured immune and metabolic markers in the nose, lungs, and blood of 15 adults. The goal was to better understand the drug's full impact beyond jus…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Portuguese study reveals how benralizumab works in real life for severe asthma
Knowledge-focused CompletedThis completed study looked back at medical records of 74 adults in Portugal with severe eosinophilic asthma who were treated with benralizumab. Researchers wanted to describe patient characteristics, treatment patterns, and outcomes in real-world settings. The study did not test…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC